Literature DB >> 19087158

Autosomal recessive hereditary spastic paraplegia with thin corpus callosum: a novel mutation in the SPG11 gene and further evidence for genetic heterogeneity.

T Pippucci1, E Panza, E Pompilii, V Donadio, A Borreca, C Babalini, C Patrono, R Zuntini, T Kawarai, G Bernardi, R Liguori, G Romeo, P Montagna, A Orlacchio, M Seri.   

Abstract

BACKGROUND AND
PURPOSE: Autosomal Recessive Hereditary Spastic Paraplegia with Thin Corpus Callosum (AR-HSPTCC) is a clinically and genetically heterogeneous complicated form of spastic paraplegia. Two AR-HSPTCC loci have been assigned to chromosome 15q13-15 (SPG11) and chromosome 8p12-p11.21 respectively. Mutations in the SPG11 gene, encoding the spatacsin protein, have been found in the majority of SPG11 families. In this study, involvement of the SPG11 or 8p12-p11.21 loci was investigated in five Italian families, of which four consanguineous.
METHODS: Families were tested for linkage to the SPG11 or 8p12-p11.21 loci and the SPG11 gene was screened in all the affected individuals.
RESULTS: Linkage was excluded in the four consanguineous families. In the only SPG11-linked family the same homozygous haplotype 4.2 cM across the SPG11 locus was shared by all the three affected siblings. A novel c.2608A>G mutation predicted to affect the splicing was found in exon 14 of the SPG11 gene. DISCUSSION: This collection of families contributes to highlight the intra and inter locus heterogeneity in AR-HSPTCC, already remarked in previous reports. In particular, it confirms heterogeneity amongst Italian families and reports a new mutation predicted to affect splicing in the spatacsin gene.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19087158     DOI: 10.1111/j.1468-1331.2008.02367.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  6 in total

1.  Atypical late-onset hereditary spastic paraplegia with thin corpus callosum due to novel compound heterozygous mutations in the SPG11 gene.

Authors:  Maria Pia Giannoccaro; Rocco Liguori; Alessia Arnoldi; Vincenzo Donadio; Patrizia Avoni; Maria Teresa Bassi
Journal:  J Neurol       Date:  2014-07-25       Impact factor: 4.849

2.  SPATACSIN mutations cause autosomal recessive juvenile amyotrophic lateral sclerosis.

Authors:  Antonio Orlacchio; Carla Babalini; Antonella Borreca; Clarice Patrono; Roberto Massa; Sarenur Basaran; Renato P Munhoz; Ekaterina A Rogaeva; Peter H St George-Hyslop; Giorgio Bernardi; Toshitaka Kawarai
Journal:  Brain       Date:  2010-01-28       Impact factor: 13.501

Review 3.  Alternative Splicing of ALS Genes: Misregulation and Potential Therapies.

Authors:  Benedetta Perrone; Valentina La Cognata; Teresa Sprovieri; Carmine Ungaro; Francesca Luisa Conforti; Sebastiano Andò; Sebastiano Cavallaro
Journal:  Cell Mol Neurobiol       Date:  2019-08-05       Impact factor: 5.046

4.  Targeted next-generation sequencing improves diagnosis of hereditary spastic paraplegia in Chinese patients.

Authors:  Cong Lu; Li-Xi Li; Hai-Lin Dong; Qiao Wei; Zhi-Jun Liu; Wang Ni; Aaron D Gitler; Zhi-Ying Wu
Journal:  J Mol Med (Berl)       Date:  2018-06-11       Impact factor: 4.599

5.  Severe axonal neuropathy is a late manifestation of SPG11.

Authors:  Andreea Manole; Viorica Chelban; Nourelhoda A Haridy; Sherifa A Hamed; Andrés Berardo; Mary M Reilly; Henry Houlden
Journal:  J Neurol       Date:  2016-08-20       Impact factor: 4.849

6.  ALS5/SPG11/KIAA1840 mutations cause autosomal recessive axonal Charcot-Marie-Tooth disease.

Authors:  Celeste Montecchiani; Lucia Pedace; Temistocle Lo Giudice; Antonella Casella; Marzia Mearini; Fabrizio Gaudiello; José L Pedroso; Chiara Terracciano; Carlo Caltagirone; Roberto Massa; Peter H St George-Hyslop; Orlando G P Barsottini; Toshitaka Kawarai; Antonio Orlacchio
Journal:  Brain       Date:  2015-11-10       Impact factor: 13.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.